Human API Raises $20M+ Funding to Scale Consumer-Controlled Health Data Ecosystem
Human API Raises $20M+ Funding to Scale Consumer-Controlled Health Data Ecosystem
Human-API

The Series C funding will be used to accelerate innovation by giving consumers a cutting-edge means of sharing health data with the enterprises and researchers putting it to good use.

Human API, a San Mateo, Calif.-based startup that enables consumers to connect and share electronic health data with companies they trust, has raised over $20 million in Series C funding. The round includes participation from Samsung Ventures, CNO Financial Group, Allianz Life Ventures, and Moneta VC, as well as from existing investors BlueRun Ventures, SCOR Life and Health Ventures, and Guardian Life Insurance Company.

Human API’s insurance customers include Prudential (Newark, N.J.) and John Hancock (Boston), which the firm says it helps to deliver consumer-centric buying experiences. Positioning itself as a driving force in health data liquidity, the company says it is working to simplify the aggregation from direct-to-EHR networks, regional HIEs, and national data networks to create seamless digital experiences that allow consumers to securely share their data with companies that can put it to good use.

“Human API’s ‘one stop shop’ of health data helps enterprises realize new possibilities in lasting consumer engagement models,” comments Paolo DeMartin, CEO, SCOR Global Life, both an investor and client of Human API. “They’re truly moving the industry into a new era of innovation.”

The company says its recent funding round positions it to build on its significant momentum in insurance and other industries including pharma and digital health, and to advance its mission to make true consumer-controlled health data liquidity a reality across a spectrum of markets.

“With this new capital we’re evolving Human API into a digital transformation platform unifying more data from more sources,” comments Andrei Pop, Founder and CEO, Human API. “We’re speeding up growth in the insurance, clinical trials, and health plans markets, as well as new use cases like COVID-19 screening.”

Human API says the new capital will be used to scale new products and services that enable new product design, granular risk stratification, optimize clinical trial recruitment, support population health management, automate patient monitoring, and digitize chronic disease management. The company says that it has brought on Richard Dufty as Chief Commercial Officer to drive this period of growth. Having spearheaded AppDirect’s growth from early stage startup to Unicorn status in just four years, and having led Symantec’s $1 billion U.S. Consumer and Cloud business, Dufty brings extensive experience launching and growing software ecosystems.

Human API describes its platform gives consumers a streamlined means of accessing and sharing their health records, opening up ways of transacting with enterprises through an intuitive experience likened to that of PayPal. “Designed to give every consumer free, simple, and full control of all their health data, the platform connects, manages, and shares data from electronic health records, pharmacies, labs, wearables, and fitness apps,” a company statement says.

 

Instant Consent and Data

“On our platform, you can easily and instantly give a digital health provider the consent and data they need to deliver you personalized care,” explains Pop. “Or, through a couple of easy steps, you could immediately enlist as part of a pharma company’s new clinical trial. Or, even, if you’re in need of life insurance, but COVID-19 prevents an in-person assessment, you can instantly send what’s required via our platform, completing the underwriting  process in 24 hours.”

“By facilitating these transactions,” says Sean Duffy, Co-Founder & CEO, Omada Health, “Human API is bringing into being a new consumer health ecosystem driven by consumer-centric health apps and services.”

Source: PropertyCasualty360

LinkedIn
Twitter
Facebook

Share this article: